290 related articles for article (PubMed ID: 29856989)
1. Aβ
Chan Y; Chen W; Wan W; Chen Y; Li Y; Zhang C
Exp Cell Res; 2018 Aug; 369(2):266-274. PubMed ID: 29856989
[TBL] [Abstract][Full Text] [Related]
2. Aβ(1-42) oligomer-induced leakage in an in vitro blood-brain barrier model is associated with up-regulation of RAGE and metalloproteinases, and down-regulation of tight junction scaffold proteins.
Wan W; Cao L; Liu L; Zhang C; Kalionis B; Tai X; Li Y; Xia S
J Neurochem; 2015 Jul; 134(2):382-93. PubMed ID: 25866188
[TBL] [Abstract][Full Text] [Related]
3. Yi-Zhi-Fang-Dai Formula Exerts a Protective Effect on the Injury of Tight Junction Scaffold Proteins in Vitro and in Vivo by Mediating Autophagy through Regulation of the RAGE/CaMKKβ/AMPK/mTOR Pathway.
Chan Y; Chen W; Chen Y; Lv Z; Wan W; Li Y; Zhang C
Biol Pharm Bull; 2020; 43(12):1847-1858. PubMed ID: 33268702
[TBL] [Abstract][Full Text] [Related]
4. Aβ
Chen W; Chan Y; Wan W; Li Y; Zhang C
Exp Cell Res; 2018 Jan; 362(1):83-89. PubMed ID: 29154819
[TBL] [Abstract][Full Text] [Related]
5. EGb761 provides a protective effect against Aβ1-42 oligomer-induced cell damage and blood-brain barrier disruption in an in vitro bEnd.3 endothelial model.
Wan WB; Cao L; Liu LM; Kalionis B; Chen C; Tai XT; Li YM; Xia SJ
PLoS One; 2014; 9(11):e113126. PubMed ID: 25426944
[TBL] [Abstract][Full Text] [Related]
6. Aβ₁₋₄₂-RAGE interaction disrupts tight junctions of the blood-brain barrier via Ca²⁺-calcineurin signaling.
Kook SY; Hong HS; Moon M; Ha CM; Chang S; Mook-Jung I
J Neurosci; 2012 Jun; 32(26):8845-54. PubMed ID: 22745485
[TBL] [Abstract][Full Text] [Related]
7. Aβ1-42 reduces P-glycoprotein in the blood-brain barrier through RAGE-NF-κB signaling.
Park R; Kook SY; Park JC; Mook-Jung I
Cell Death Dis; 2014 Jun; 5(6):e1299. PubMed ID: 24967961
[TBL] [Abstract][Full Text] [Related]
8. Adiponectin controls the apoptosis and the expression of tight junction proteins in brain endothelial cells through AdipoR1 under beta amyloid toxicity.
Song J; Choi SM; Whitcomb DJ; Kim BC
Cell Death Dis; 2017 Oct; 8(10):e3102. PubMed ID: 29022894
[TBL] [Abstract][Full Text] [Related]
9. Amyloid Beta 25-35 induces blood-brain barrier disruption in vitro.
Cuevas E; Rosas-Hernandez H; Burks SM; Ramirez-Lee MA; Guzman A; Imam SZ; Ali SF; Sarkar S
Metab Brain Dis; 2019 Oct; 34(5):1365-1374. PubMed ID: 31267346
[TBL] [Abstract][Full Text] [Related]
10. Amyloid Beta induces oxidative stress-mediated blood-brain barrier changes in capillary amyloid angiopathy.
Carrano A; Hoozemans JJ; van der Vies SM; Rozemuller AJ; van Horssen J; de Vries HE
Antioxid Redox Signal; 2011 Sep; 15(5):1167-78. PubMed ID: 21294650
[TBL] [Abstract][Full Text] [Related]
11. 1,25-Dihydroxyvitamin D3 regulates expression of LRP1 and RAGE in vitro and in vivo, enhancing Aβ1-40 brain-to-blood efflux and peripheral uptake transport.
Guo YX; He LY; Zhang M; Wang F; Liu F; Peng WX
Neuroscience; 2016 May; 322():28-38. PubMed ID: 26820600
[TBL] [Abstract][Full Text] [Related]
12. Catalpol provides a protective effect on fibrillary Aβ
Liu C; Chen K; Lu Y; Fang Z; Yu G
Phytother Res; 2018 Jun; 32(6):1047-1055. PubMed ID: 29479743
[TBL] [Abstract][Full Text] [Related]
13. CCR5 antagonist reduces HIV-induced amyloidogenesis, tau pathology, neurodegeneration, and blood-brain barrier alterations in HIV-infected hu-PBL-NSG mice.
Bhargavan B; Woollard SM; McMillan JE; Kanmogne GD
Mol Neurodegener; 2021 Nov; 16(1):78. PubMed ID: 34809709
[TBL] [Abstract][Full Text] [Related]
14. Targeted inhibition of RAGE reduces amyloid-β influx across the blood-brain barrier and improves cognitive deficits in db/db mice.
Wang H; Chen F; Du YF; Long Y; Reed MN; Hu M; Suppiramaniam V; Hong H; Tang SS
Neuropharmacology; 2018 Mar; 131():143-153. PubMed ID: 29248482
[TBL] [Abstract][Full Text] [Related]
15. Effect of Zhenxin Xingshui Yizhi Fang on Aβ
Wu L; Zheng Q; Guo YY; Zhang KN; Luo J; Xiao S; Li WJ; Yang M
J Ethnopharmacol; 2020 Oct; 260():112783. PubMed ID: 32240783
[TBL] [Abstract][Full Text] [Related]
16. Effect of High Cholesterol Regulation of LRP1 and RAGE on Aβ Transport Across the Blood-Brain Barrier in Alzheimer's Disease.
Zhou R; Chen LL; Yang H; Li L; Liu J; Chen L; Hong WJ; Wang CG; Ma JJ; Huang J; Zhou XF; Liu D; Zhou HD
Curr Alzheimer Res; 2021; 18(5):428-442. PubMed ID: 34488598
[TBL] [Abstract][Full Text] [Related]
17. Changes of blood-brain-barrier function and transfer of amyloid beta in rats with collagen-induced arthritis.
Lai PH; Wang TH; Zhang NY; Wu KC; Yao CJ; Lin CJ
J Neuroinflammation; 2021 Jan; 18(1):35. PubMed ID: 33516259
[TBL] [Abstract][Full Text] [Related]
18. Annexin A1 restores Aβ
Park JC; Baik SH; Han SH; Cho HJ; Choi H; Kim HJ; Choi H; Lee W; Kim DK; Mook-Jung I
Aging Cell; 2017 Feb; 16(1):149-161. PubMed ID: 27633771
[TBL] [Abstract][Full Text] [Related]
19. The potential mechanisms of Aβ-receptor for advanced glycation end-products interaction disrupting tight junctions of the blood-brain barrier in Alzheimer's disease.
Wan W; Chen H; Li Y
Int J Neurosci; 2014 Feb; 124(2):75-81. PubMed ID: 23855502
[TBL] [Abstract][Full Text] [Related]
20. RAGE-NF-κB-PPARγ Signaling is Involved in AGEs-Induced Upregulation of Amyloid-β Influx Transport in an In Vitro BBB Model.
Chen F; Ghosh A; Hu M; Long Y; Sun H; Kong L; Hong H; Tang S
Neurotox Res; 2018 Feb; 33(2):284-299. PubMed ID: 28871412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
